{
    "2021-04-14": [
        [
            {
                "time": "2023-04-26",
                "original_text": "医美概念爆发，外资大幅加仓3股，机构看好这些股",
                "features": {
                    "keywords": [
                        "医美",
                        "外资",
                        "加仓",
                        "机构看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "美容"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "217家A股药企年报：复星医药研发40亿居榜首，诊断类企业净利润增幅超6000%，还有5家公司净利润降幅超1000%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "研发",
                        "净利润",
                        "增幅",
                        "降幅"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "“少女针”火了，医美概念爆发，7连板爆炒股上演地天板，外资加仓这些概念股",
                "features": {
                    "keywords": [
                        "少女针",
                        "医美",
                        "外资加仓",
                        "连板"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "美容"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "复星医药(02196.HK)4月26日举行董事会会议审批一季度业绩",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事会",
                        "一季度业绩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "复星系赋能，金徽酒发展再提速",
                "features": {
                    "keywords": [
                        "复星系",
                        "金徽酒",
                        "发展提速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "酒业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "恒瑞医药虚开经费送礼 上海医药财务造假7736万被指管理混乱 欺诈造假",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "虚开经费",
                        "上海医药",
                        "财务造假",
                        "管理混乱"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "财政部彻查恒瑞医药虚开经费送礼 上海医药财务造假7736万被指管理混乱 欺诈造假",
                "features": {
                    "keywords": [
                        "财政部",
                        "彻查",
                        "恒瑞医药",
                        "虚开经费",
                        "上海医药",
                        "财务造假"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}